Drug-labels.com

Sumatriptan (Cobalt Pharmaceuticals): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
25 mg, 50 mg, 100 mg

Patient Medication Information: uses, side effects, how to take - Sumatriptan (Cobalt Pharmaceuticals)

ABOUT THIS MEDICATION

The name of your medicine is SUMATRIPTAN (sumatriptan succinate) Tablets. They can be obtained only by prescription from your doctor. The decision to use SUMATRIPTAN Tablets is one that you and your doctor should make jointly, taking into account your individual preferences and medical circumstances. If you have risk factors for heart disease (such as high blood pressure, high cholesterol, obesity, diabetes, smoking, strong family history of heart disease, or you are postmenopausal or a male over 40), you should tell your doctor, who should evaluate you for heart disease in order to determine if SUMATRIPTAN Tablets are appropriate for you.

What the medication is used for:

SUMATRIPTAN Tablets are intended to relieve your migraine headache and other associated symptoms of a migraine attack. SUMATRIPTAN Tablets should not be used continuously to prevent or reduce the number of attacks you experience. Use SUMATRIPTAN Tablets only to treat an actual migraine headache attack.

What it does:

Migraine headache is believed to be caused by a widening of the blood vessels in the head. SUMATRIPTAN narrows these vessels and relieves the symptoms of migraine headache.

When it should not be used:

Do not use SUMATRIPTAN Tablets if:

  • you are allergic to sumatriptan succinate or to any of the ingredients in SUMATRIPTAN Tablets. (See “What the nonmedicinal ingredients are:”)
  • you have a history, or any symptoms or signs of a heart condition
  • you have high blood pressure
  • you are taking or have recently taken (within 2 weeks) a monoamine oxidase inhibitor (MAOI)
  • you are taking or have recently taken (within 24 hours)

    an ergotamine containing medication or its derivatives, or another triptan used to treat migraine

  • you have severe liver disease

SUMATRIPTAN Tablets should not be used for the

treatment of other types of headaches that are different from migraine attacks.

What the medicinal ingredient is:

Sumatriptan succinate

What the important nonmedicinal ingredients are: The following inactive ingredients are common to all tablet strengths: croscarmellose sodium, lactose, magnesium stearate, and microcrystalline cellulose.

In addition, the 100 mg tablet also contains Red 30 Iron Oxide as an inactive ingredient.

SUMATRIPTAN tablets are gluten free.

For a full listing of nonmedicinal ingredients see Part 1 of the product monograph.

What dosage forms it comes in:

Tablets, 25 mg, 50 mg, and 100 mg

WARNINGS AND PRECAUTIONS

BEFORE you use SUMATRIPTAN Tablets talk to your doctor or pharmacist if:

  • you are pregnant, think you might be pregnant, you are trying to become pregnant, you are using inadequate contraception, or you are breast-feeding

  • you have any chest pain, heart disease, shortness of breath, or irregular heartbeats, you have had a heart attack, or you have angina.
  • you have risk factors for heart disease (such as high blood pressure, high cholesterol, obesity, diabetes, smoking, strong family history of heart disease, or are you postmenopausal or a male over 40).
  • you have ever had to stop taking this or any other medication because of an allergy or other problems, or you are allergic to sulpha-containing drugs
  • you are taking any medications, including migraine medications such as 5-HT1 agonists or those containing ergotamine, dihydroergotamine, or methysergide ③ you have ever experienced difficulty moving one side of your body when you have a headache
  • you have ever had a stroke, transient ischemic attacks (TIAs), or Raynaud Syndrome
  • you are under 18 years of age
  • you are over 65 years of age
  • you are taking any medication for depression (lithium, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors (SSRIs), or serotonin noradrenaline reuptake inhibitors (SNRIs)
  • you had, or you have any disease of the liver or kidney ③ you had, or you have epilepsy or seizures
  • this headache is different from your usual migraine attacks

SUMATRIPTAN Tablets should not be used continuously to prevent or reduce the number of attacks you experience. Use SUMATRIPTAN Tablets only to treat actual migraine headache

attack.

If you use SUMATRIPTAN Tablets too often, it may make your headaches worse. If this happens, your doctor may tell you to stop taking SUMATRIPTAN Tablets.

The Use of SUMATRIPTAN Tablets During Pregnancy:

Do not use SUMATRIPTAN Tablets if you are pregnant, think you might be pregnant, are trying to become pregnant, or are not using adequate contraception, unless you have discussed this with your doctor.

INTERACTIONS WITH THIS MEDICATION

Do not use SUMATRIPTAN Tablets if you are taking or have recently taken monoamine oxidase inhibitors (MAOI) in the last two weeks, or any migraine medications containing ergotamine, ergot derivatives (such as dihydroergotamine, or methysergide), or other triptans used to treat migraine within 24 hours.

You should tell your doctor if you are taking or have recently taken any other medications (prescription, non-prescription or natural/herbal), before you start taking SUMATRIPTAN Tablets, especially any antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and certain tricyclics.

PROPER USE OF THIS MEDICATION

The label of the container of your medicine or the leaflet inside should tell you how often to take a dose and the amount you should take in each dose. If it does not or you are not sure, ask your doctor or pharmacist. DO NOT take more medicine or take your medicine more often than you are told.

Usual dose:

Adults: Take as directed by your doctor. If the first tablet does not relieve your headache, do not take further doses of sumatriptan for the same attack. You may take pain medication other than ergotamine-containing preparations for further pain relief. SUMATRIPTAN may be taken for subsequent attacks. SUMATRIPTAN Tablets can be taken at any time during your migraine headache.

If your symptoms come back, and it has been two hours since your first tablet, you may take a second tablet.

Do not take more than 200 mg in any 24 hour period.

SUMATRIPTAN Tablets may be taken with or without food. The tablet should be swallowed whole with water. It should not be crushed, chewed or split.

Overdose:

If you have taken more medication than you have been told, contact either your doctor, hospital emergency department, or nearest poison control center immediately.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medications, sumatriptan succinate tablets can cause some side effects. You may not experience any of them. For most patients these side effects are likely to be minor and temporary. However, some may be serious. Consult your doctor if you experience these or other side effects.

The most commonly reported side effects of sumatriptan succinate Tablets are:

  • pain, pressure or tightness in any part of the body, including chest and throat
  • sensations of heaviness
  • unusual sensations including numbness, tingling, heat/burning or cold
  • flushing (redness of the face lasting for a short time) ③ feeling sick or vomiting
  • dizziness
  • drowsiness
  • tiredness
  • weakness

As drowsiness may occur as a result of using SUMATRIPTAN Tablets, do not drive or operate machinery until you are sure that you are not drowsy.

Other side effects include:

  • unusually slow or fast heartbeats, a feeling of irregular and/or forceful heartbeats
  • visual disturbances, usually temporary (scotoma, nystagmus, flickering, diplopia).
  • dystonia, (shaking, tremors or uncontrolled movements) ③ loss of normal colouration in the fingers and toes.

Tell your doctor of these symptoms at your next visit. Very rarely, some people have reported the following more serious side effects. For information on what to do if you experience these side effects, see the table at the end of this section.

  • pain or tightness in the chest or throat
  • loss of vision
  • shortness of breath; wheeziness; chest tightening; swelling of eyelids, face, or lips; or a skin rash, skin lumps ③ a seizure or fit
  • sudden and/or severe abdominal pain
  • persistent purple discolouration of hands or feet

If you feel unwell in any other way or have any symptoms that you do not understand or find distressing, you should contact your doctor immediately.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN

AND WHAT TO DO ABOUT THEM

Symptom / effectTalk with your doctor or pharmacist

Stop

taking drug and call your doctor or pharmacist

Only if

severe

In all cases
CommonUnusual sensations including numbness, tingling, feeling hot or cold; pain, heaviness or pressure in any part of the body including chest and throat.T
Very rareSymptoms of a heart attack [chest pain, sweating, shortness of breath].T
Very rareUnusually slow or fast heartbeats, or a feeling of irregular and/or forceful heartbeats.T
Very rareAllergic reactions [shortness of breath, sudden wheeziness, chest tightness, swelling of the eyelids face or lips, lumpy skin rash or hives]T
Very rareSeizures [loss of consciousness with uncontrollable shaking (“fit”)]T
Very rareLower abdominal pain and/or severe rectal bleeding.T
Very rare

Raynaud’s phenomenon [persistent purple

discolouration of hands or feet].

T
Very rareLoss of vision.TT

This is not a complete list of side effects. For any unexpected effects while taking SUMATRIPTAN Tablets, contact your doctor or pharmacist.

HOW TO STORE IT

Keep your medicine in a safe place where children cannot reach it. It may be harmful to children.

Keep your tablets in a cool, dry place (15EC to 30EC).

If your medication has expired (the expiration date is printed on the treatment pack), throw it away as instructed.

If your doctor decides to stop your treatment, do not keep any leftover medicine unless your doctor tells you to. Throw away your medicine as instructed.

Reminder:

REMEMBER: This medicine is for you. Only a doctor can prescribe it for you. Never give it to someone else. It may harm them even if their symptoms appear to be similar to yours.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

---------------------------------------------------------------------------- $ Report online at www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345

$ Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program Health Canada

    Postal Locator 0701C

    Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the
management of side effects, contact your health professional.
The Canada Vigilance Program does not provide medical
advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, Cobalt Pharmaceuticals Inc. at: 1-866-254-6111

Last revised: February 22, 2010.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02344718

Revision date stated in the text: February 22, 2010

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Sumatriptan (Cobalt Pharmaceuticals)

Rx or OTC
Prescription (Rx)?
DIN 02344718, 02344726, 02344734
Schedule(s) PRESCRIPTION
Active ingredient(s) Sumatriptan (sumatriptan succinate)
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02C Antimigraine preparations
        1. N02CC Selective serotonin (5HT1) agonists, antimigraine drugs
          1. N02CC01 Sumatriptan
Company COBALT PHARMACEUTICALS COMPANY
Current status Cancelled Pre Market
Current status date September 1, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
02344718 25 MG Tablet Cancelled Pre Market September 1, 2017
02344726 50 MG Tablet Cancelled Pre Market September 1, 2017
02344734 100 MG Tablet Cancelled Pre Market September 1, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.